These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26927097)

  • 21. Enzyme replacement therapy in lysosomal acid lipase deficiency (LAL-D): a systematic literature review.
    Bashir A; Tiwari P; Duseja A
    Ther Adv Rare Dis; 2021; 2():26330040211026928. PubMed ID: 37181111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lysosomal acid lipase deficiency: Expanding differential diagnosis.
    Valayannopoulos V; Mengel E; Brassier A; Grabowski G
    Mol Genet Metab; 2017; 120(1-2):62-66. PubMed ID: 27876313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lysosomal acid lipase deficiency (LAL-D) : Diagnostic and therapeutic options in an underdiagnosed disease].
    Synoracki S; Kathemann S; Schmid KW; Jastrow H; Baba HA
    Pathologe; 2018 May; 39(3):249-254. PubMed ID: 29234937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low levels of Lysosomal Acid Lipase (LAL) activity increases necroinflammation in adult patients with biopsy-proven metabolic associated fatty liver disease.
    Thoen RU; Longo L; Neto SC; Álvares-da-Silva MR
    Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101638. PubMed ID: 33662773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Could lysosomal acid lipase enzyme activity be used for clinical follow-up in cryptogenic cirrhosis?
    Köse E; Çağatay E; Yaraş T; Kısa PT; Güler S; Gülten ZA; Akarsu M; Oktay Y; Kayalı HA; Arslan N
    Turk J Med Sci; 2022 Aug; 52(4):1075-1084. PubMed ID: 36326406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sebelipase alfa in children and adults with lysosomal acid lipase deficiency: Final results of the ARISE study.
    Burton BK; Feillet F; Furuya KN; Marulkar S; Balwani M
    J Hepatol; 2022 Mar; 76(3):577-587. PubMed ID: 34774639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular and histological traits of reduced lysosomal acid lipase activity in the fatty liver.
    Carotti S; Lettieri-Barbato D; Piemonte F; Ruggiero S; Rosina M; Zalfa F; Zingariello M; Arciprete F; Valentini F; Francesconi M; D'Amico J; De Vincentis A; Baiocchini A; Perrone G; Antonelli-Incalzi R; Morini S; Picardi A; Aquilano K; Vespasiani-Gentilucci U
    Cell Death Dis; 2021 Nov; 12(12):1092. PubMed ID: 34795230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extended use of a selective inhibitor of acid lipase for the diagnosis of Wolman disease and cholesteryl ester storage disease.
    Civallero G; De Mari J; Bittar C; Burin M; Giugliani R
    Gene; 2014 Apr; 539(1):154-6. PubMed ID: 24508470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and metabolic profiling of patients with lysosomal acid lipase deficiency.
    Pullinger CR; Stock EO; Movsesyan I; Malloy MJ; Frost PH; Tripuraneni R; Quinn AG; Ishida BY; Schaefer EJ; Asztalos BF; Kane JP
    J Clin Lipidol; 2015; 9(5):716-26.e1. PubMed ID: 26350820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A practical fluorometric assay method to measure lysosomal acid lipase activity in dried blood spots for the screening of cholesteryl ester storage disease and Wolman disease.
    Dairaku T; Iwamoto T; Nishimura M; Endo M; Ohashi T; Eto Y
    Mol Genet Metab; 2014 Feb; 111(2):193-6. PubMed ID: 24295952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic lysosomal acid lipase overexpression worsens hepatic inflammation in mice fed a Western diet.
    Lopresti MW; Cui W; Abernathy BE; Fredrickson G; Barrow F; Desai AS; Revelo XS; Mashek DG
    J Lipid Res; 2021; 62():100133. PubMed ID: 34624333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Features of Lysosomal Acid Lipase Deficiency.
    Burton BK; Deegan PB; Enns GM; Guardamagna O; Horslen S; Hovingh GK; Lobritto SJ; Malinova V; McLin VA; Raiman J; Di Rocco M; Santra S; Sharma R; Sykut-Cegielska J; Whitley CB; Eckert S; Valayannopoulos V; Quinn AG
    J Pediatr Gastroenterol Nutr; 2015 Dec; 61(6):619-25. PubMed ID: 26252914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An overview of deregulated lipid metabolism in nonalcoholic fatty liver disease with special focus on lysosomal acid lipase.
    Carotti S; Aquilano K; Valentini F; Ruggiero S; Alletto F; Morini S; Picardi A; Antonelli-Incalzi R; Lettieri-Barbato D; Vespasiani-Gentilucci U
    Am J Physiol Gastrointest Liver Physiol; 2020 Oct; 319(4):G469-G480. PubMed ID: 32812776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deletion of sterol O-acyltransferase 2 (SOAT2) function in mice deficient in lysosomal acid lipase (LAL) dramatically reduces esterified cholesterol sequestration in the small intestine and liver.
    Lopez AM; Posey KS; Turley SD
    Biochem Biophys Res Commun; 2014 Nov; 454(1):162-6. PubMed ID: 25450374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver disease and dyslipidemia as a manifestation of lysosomal acid lipase deficiency (LAL-D). Clinical and diagnostic aspects, and a new treatment. An update.
    Bay L; Canero Velasco C; Ciocca M; Cotti A; Cuarterolo M; Fainboim A; Fassio E; Galoppo M; Pinero F; Rozenfeld P
    Arch Argent Pediatr; 2017 Jun; 115(3):287-293. PubMed ID: 28504497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel LIPA mutations in Mexican siblings with lysosomal acid lipase deficiency.
    Santillán-Hernández Y; Almanza-Miranda E; Xin WW; Goss K; Vera-Loaiza A; Gorráez-de la Mora MT; Piña-Aguilar RE
    World J Gastroenterol; 2015 Jan; 21(3):1001-8. PubMed ID: 25624737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysosomal acid lipase deficiency manifestations in children and adults: Baseline data from an international registry.
    Balwani M; Balistreri W; D'Antiga L; Evans J; Ros E; Abel F; Wilson DP
    Liver Int; 2023 Jul; 43(7):1537-1547. PubMed ID: 37222260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Frequency of Lysosomal Acid Lipase Deficiency in Children With Unexplained Liver Disease.
    Kuloglu Z; Kansu A; Selbuz S; Kalaycı AG; Şahin G; Kirsaclioglu CT; Demirören K; Dalgıç B; Kasırga E; Önal Z; İşlek A;
    J Pediatr Gastroenterol Nutr; 2019 Mar; 68(3):371-376. PubMed ID: 30540705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for lysosomal acid lipase deficiency: A retrospective data mining study and evaluation of screening criteria.
    Draijer LG; Bosch AM; Wiegman A; Sjouke B; Benninga MA; Koot BGP
    Atherosclerosis; 2018 Nov; 278():174-179. PubMed ID: 30286343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a common missense variant in LIPA gene on fatty liver disease and lipid phenotype: New perspectives from a single-center observational study.
    Pasta A; Borro P; Cremonini AL; Formisano E; Tozzi G; Cecchi S; Fresa R; Labanca S; Djahandideh A; Sukkar SG; Picciotto A; Pisciotta L
    Pharmacol Res Perspect; 2021 Oct; 9(5):e00820. PubMed ID: 34476902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.